Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
4400 participants
OBSERVATIONAL
2026-04-30
2032-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating Attention Patterns in Young People With Anxiety
NCT03546946
Interpretation Bias as a Mechanism of Treatment Response in OCD
NCT05224414
Cognitive Bias Modification for OCD
NCT03799419
Threat-Avoidance Learning in Anxiety Patients
NCT02336802
An Investigation of General Predictors for CBT Outcome for Anxiety Disorders in a Naturalistic Setting
NCT02638363
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Learning Effective New Strategies (LENS)
Learning Effective New Strategies (LENS) is a Class I digital mental health intervention developed by King's College London, of which the overall purpose is to shift the way people think about ambiguous situations to be more positive and helpful. LENS achieves this through a drill-like training where users are prompted to visualise positive conclusions to numerous situations which are ambiguous and could be interpreted in either negative or positive ways. This training involves completing 12 sessions over 4 weeks. This type of training is known as cognitive bias modification for interpretation bias (CBM-I), which trains individuals to think in a more positive, adaptive way. The intended use of LENS is to reduce anxiety, depression and/or repetitive negative thinking in individuals with anxiety (low to high levels), depression (low to moderate levels), and/or repetitive negative thinking (moderate to high levels).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent in English
* Normal or corrected to normal hearing
* Normal or corrected to normal vision
* Currently experiencing anxiety (GAD-7 score ≥ 8)
* Access to stable internet connection
* Access to smartphone, laptop, computer, or tablet
Exclusion Criteria
* Suicide attempt in past two years.
* Current or history of psychosis or bipolar disorder.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Colette R Hirsch
Role: PRINCIPAL_INVESTIGATOR
King's College London
Thalia Eley
Role: PRINCIPAL_INVESTIGATOR
King's College London
Gerome Breen
Role: PRINCIPAL_INVESTIGATOR
King's College London
Ewan Carr
Role: PRINCIPAL_INVESTIGATOR
King's College London
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
363721
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.